Skip to content

Harrow HROW Total debt

Total debt at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$5.04B+4.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$79.46M+4.2%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$20.76B-3.5%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$88.68M+22.5%
AbbVie logo
AbbVieABBV
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

Plus components not separately reported this period.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's total debt?
Harrow (HROW) reported total debt of $308.58M in Q1 2026.
How has Harrow's total debt changed year-over-year?
Harrow's total debt decreased by 32.9% year-over-year, from $459.93M to $308.58M.
What is the long-term trend for Harrow's total debt?
Over 5 years (2020 to 2025), Harrow's total debt has grown at a 56.8% compound annual growth rate (CAGR), from $27.27M to $258.79M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.